Literature DB >> 12475826

Volume of pleural fluid required for diagnosis of pleural malignancy.

Susan M Sallach1, John A Sallach, Eduardo Vasquez, Lonni Schultz, Paul Kvale.   

Abstract

STUDY
OBJECTIVES: To determine if the diagnosis of pleural malignancy is dependent on the volume of pleural fluid sampled. DESIGN AND
SETTING: Single-center retrospective chart review. PATIENTS: Two hundred eighty-two patients who underwent diagnostic thoracentesis between October 1, 1998, and June 30, 1999.
INTERVENTIONS: Charts were analyzed for volume of fluid, pathologic and clinical diagnoses, and demographics. Patients were classified into quartiles based on the volume of pleural fluid collected. Sensitivity and negative predictive value (NPV) were calculated for each quartile for diagnosis of pleural malignancy by cytology of pleural fluid. Further analyses were done regarding the effect of sex, race, age, smoking history, and personal history of malignancy on diagnosis.
RESULTS: In total, 374 samples from 282 patients were identified (140 men and 142 women). Pleural malignancy within 6 months of initial thoracentesis was diagnosed in 99 patients (35.1%). No differences were detected for sensitivity and NPV for diagnosis of pleural malignancy between any two quartiles (p > 0.05). Samples collected from women had a higher sensitivity for predicting pleural malignancy (p = 0.0011), and those collected from nonsmokers had a slightly higher but not statistically significant sensitivity for predicting pleural malignancy (p = 0.057). Samples collected from subjects with no history of malignancy had a significantly higher NPV than samples collected from subjects with a history of malignancy (p < 0.001). After adjusting for these demographic and medical history factors, the associations of the pleural fluid volume quartiles with sensitivity and NPV did not change.
CONCLUSION: The sensitivity for diagnosis of pleural malignancy is not dependent on the volume of pleural fluid extracted during thoracentesis.

Entities:  

Mesh:

Year:  2002        PMID: 12475826     DOI: 10.1378/chest.122.6.1913

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival.

Authors:  Oleg Mironov; Nicole M Ishill; Svetlana Mironov; Hebert Alberto Vargas; Junting Zheng; Chaya S Moskowitz; Yukio Sonoda; Ralph S Papas; Dennis S Chi; Hedvig Hricak
Journal:  Radiology       Date:  2010-12-30       Impact factor: 11.105

2.  Effectiveness of Video-Assisted Thoracoscopic Surgery in Undiagnosed Exudative Pleural Effusions.

Authors:  Erdoğan Dadaş; Eren Erdoğdu; Alper Toker; Miray Ersöz; Tamer Okay
Journal:  Turk Thorac J       Date:  2019-04-09

3.  Medical Thoracoscopy vs Closed Pleural Biopsy in Pleural Effusions: A Randomized Controlled Study.

Authors:  Nithya Haridas; Suraj K P; Rajagopal T P; James P T; Ravindran Chetambath
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 4.  Malignant pleural effusion and algorithm management.

Authors:  Konstantinos Zarogoulidis; Paul Zarogoulidis; Kaid Darwiche; Kosmas Tsakiridis; Nikolaos Machairiotis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Eirini Terzi; Bojan Zaric; Haidong Huang; Lutz Freitag; Dionysios Spyratos
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

Review 5.  The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.

Authors:  Michael Bradshaw; Aaron Mansfield; Tobias Peikert
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

6.  A new, simple method for estimating pleural effusion size on CT scans.

Authors:  Matthew P Moy; Jeffrey M Levsky; Netanel S Berko; Alla Godelman; Vineet R Jain; Linda B Haramati
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

7.  Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.

Authors:  Oleg Mironov; Evis Sala; Svetlana Mironov; Harpreet Pannu; Dennis S Chi; Hedvig Hricak
Journal:  J Gynecol Oncol       Date:  2011-12-05       Impact factor: 4.401

8.  Pleural fluid analysis: standstill or a work in progress?

Authors:  T Hassan; M Al-Alawi; S H Chotirmall; N G McElvaney
Journal:  Pulm Med       Date:  2012-02-01

9.  Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.

Authors:  Till Braunschweig; Joon-Yong Chung; Chel Hun Choi; Hanbyoul Cho; Qing-Rong Chen; Ran Xie; Candice Perry; Javed Khan; Stephen M Hewitt
Journal:  Diagn Pathol       Date:  2015-05-29       Impact factor: 2.644

10.  The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study.

Authors:  Huimin Wu; Rahul Khosla; Prashant K Rohatgi; Suman S Chauhan; Edina Paal; Wen Chen
Journal:  Lung India       Date:  2017 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.